Literature DB >> 26201638

Short- and long-term clinical outcome after balloon-occluded retrograde transvenous obliteration: is pretreatment portal flow direction a predictive factor?

Hidehiro Kamezaki1, Hitoshi Maruyama2, Taro Shimada1, Masanori Takahashi1, Hidehiro Okugawa1, Osamu Yokosuka1.   

Abstract

PURPOSE: To determine whether pretreatment portal flow direction can predict different clinical manifestations or prognosis after balloon-occluded retrograde transvenous obliteration (B-RTO) for gastric varices.
METHODS: The subjects were 103 cirrhotic patients with medium- or large-grade gastric varices treated by B-RTO. Short- and long-term clinical outcomes were compared among patients with forward portal flow (F group) and those with reversed or to-and-fro portal flow (R group) on color Doppler sonography before B-RTO.
RESULTS: Deterioration of liver function reserve 1 year after B-RTO was more frequent in the R group (34.7 %) than in the F group (11.1 %, p = 0.0251). Thrombotic disorders within 1 year after B-RTO were also more frequent in the R group (20.7 %) than in the F group (2.7 %, p = 0.0079). There was no significant difference in cumulative survival rate of Child class A patients between the two groups. In Child class B or class C patients, however, the cumulative survival rate was poorer in the R group (68.7, 30.5, and 30.5 % at 1, 5, and 9 years, respectively) than in the F group (94.9, 58.8, and 37.8 % and 1, 5, and 9 years, respectively; p = 0.0097).
CONCLUSIONS: Hemodynamic assessment of portal flow direction is important before B-RTO, and care should be taken to manage thrombotic disorders in the perioperative period in patients with reversed portal flow after B-RTO. Another treatment option might be preferred for gastric varices in Child classes B and C patients with reversed portal flow instead of B-RTO, which may have a poor prognosis.

Entities:  

Keywords:  Balloon-occluded retrograde transvenous obliteration (B-RTO); Doppler ultrasound; Gastric varices; Portal hypertension

Year:  2012        PMID: 26201638     DOI: 10.1007/s12072-012-9376-1

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  20 in total

1.  Relative frequencies of portosystemic pathways and renal shunt formation through the "posterior" gastric vein: portographic study in 460 patients.

Authors:  K Kimura; M Ohto; S Matsutani; J Furuse; K Hoshino; K Okuda
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

2.  Virchow's contribution to the understanding of thrombosis and cellular biology.

Authors:  David R Kumar; Erin Hanlin; Ingrid Glurich; Joseph J Mazza; Steven H Yale
Journal:  Clin Med Res       Date:  2010-08-25

3.  The natural history and prognostic factors in patients with cirrhosis and gastric fundal varices without prior bleeding.

Authors: 
Journal:  Hepatol Res       Date:  2000-05       Impact factor: 4.288

4.  Therapeutic effect of balloon-occluded retrograde transvenous obliteration for gastric varices in relation to haemodynamics in the short gastric vein.

Authors:  H Okugawa; H Maruyama; S Kobayashi; H Yoshizumi; S Matsutani; O Yokosuka
Journal:  Br J Radiol       Date:  2009-05-26       Impact factor: 3.039

5.  Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration.

Authors:  H Kanagawa; S Mima; H Kouyama; K Gotoh; T Uchida; K Okuda
Journal:  J Gastroenterol Hepatol       Date:  1996-01       Impact factor: 4.029

6.  Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension: effects of obliteration of major portosystemic shunts.

Authors:  R Shimoda; K Horiuchi; S Hagiwara; H Suzuki; Y Yamazaki; T Kosone; T Ichikawa; H Arai; T Yamada; T Abe; H Takagi; M Mori
Journal:  Abdom Imaging       Date:  2005 May-Jun

7.  Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients.

Authors:  Teruhisa Ninoi; Norifumi Nishida; Toshio Kaminou; Yukimasa Sakai; Toshiaki Kitayama; Masao Hamuro; Ryusaku Yamada; Kenji Nakamura; Tetsuo Arakawa; Yuichi Inoue
Journal:  AJR Am J Roentgenol       Date:  2005-04       Impact factor: 3.959

8.  Risk factors for hemorrhage from gastric fundal varices.

Authors:  T Kim; H Shijo; H Kokawa; H Tokumitsu; K Kubara; K Ota; N Akiyoshi; T Iida; M Yokoyama; M Okumura
Journal:  Hepatology       Date:  1997-02       Impact factor: 17.425

9.  The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration.

Authors:  Nobuhiko Hiraga; Hiroshi Aikata; Shintaro Takaki; Hideaki Kodama; Hiroo Shirakawa; Michio Imamura; Yoshiiku Kawakami; Shoichi Takahashi; Naoyuki Toyota; Katsuhide Ito; Shinji Tanaka; Mikiya Kitamoto; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

10.  Endoscopic injection sclerosis in bleeding gastric varices.

Authors:  W Trudeau; T Prindiville
Journal:  Gastrointest Endosc       Date:  1986-08       Impact factor: 9.427

View more
  4 in total

1.  Reversed portal flow: Clinical influence on the long-term outcomes in cirrhosis.

Authors:  Takayuki Kondo; Hitoshi Maruyama; Tadashi Sekimoto; Taro Shimada; Masanori Takahashi; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

Review 2.  Advances in ultrasound diagnosis in chronic liver diseases.

Authors:  Hitoshi Maruyama; Naoya Kato
Journal:  Clin Mol Hepatol       Date:  2019-02-18

3.  Left Gastric Vein Width Is an Important Risk Factor for Exacerbation of Esophageal Varices Post Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Cirrhotic Patients.

Authors:  Taku Mizutani; Kazushige Nirei; Tatsuo Kanda; Masayuki Honda; Tomotaka Ishii; Shuhei Arima; Yoichiro Yamana; Naoki Matsumoto; Shunichi Matsuoka; Mitsuhiko Moriyama
Journal:  Medicina (Kaunas)       Date:  2022-01-28       Impact factor: 2.430

4.  Balloon-occluded retrograde transvenous obliteration for gastric varices improves hepatic functional reserve in long-term follow-up.

Authors:  Nobuo Waguri; Akihiko Osaki; Yusuke Watanabe; Tsuyoshi Matsubara; Shun Yamazaki; Hanako Yokoyama; Kiwamu Kimura; Takuya Wakabayashi; Masaki Mito; Shunta Yakubo; Rie Azumi; Junji Kohisa; Kennichi Takaku; Munehiro Sato; Kouichi Furukawa
Journal:  JGH Open       Date:  2021-11-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.